Business Context and Reporting Period
This Form 8-K is filed by Medical Transcription Billing, Corp. (MTBC) on December 29, 2016. The registrant operates in the medical transcription and billing sector. The report addresses a specific regulatory event regarding the company's listing status on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on compliance with listing standards rather than financial performance metrics.
Material Changes and Listing Status
- Nasdaq Non-Compliance: The company previously failed to meet the minimum $1.00 bid price requirement for 30 consecutive business days prior to June 30, 2016.
- Extension Granted: On December 22, 2016, Nasdaq granted MTBC an additional 180-day compliance period, extending until June 19, 2017.
- Eligibility Criteria: The extension was granted because the company met all other initial listing requirements, including the market value of publicly held shares, despite the bid price deficiency.
- Trading Status: The notification of noncompliance has no immediate effect on the listing or trading of MTBC common stock under the symbol "MTBC."
Outlook, Management Commentary, and Risks
Management intends to monitor the closing bid price of its common stock. To regain compliance, the closing bid price must reach at least $1.00 per share for a minimum of ten consecutive business days. The company stated it may consider implementing available options, including a reverse stock split, if necessary to cure the deficiency during the second compliance period.
Investor Verification Checklist
- Verify the current closing bid price of MTBC stock relative to the $1.00 threshold.
- Monitor for any shareholder meetings or proposals regarding a reverse stock split.
- Confirm the company's progress toward the June 19, 2017, compliance deadline.
- Review subsequent filings for updates on the market value of publicly held shares.